Evidence mapPaperPMID 41507664Full record

ArticleNature metabolism2026

A catecholamine-independent pathway controlling adaptive adipocyte lipolysis.

Xiao Zhang, Sreejith S Panicker, Jordan M Bollinger, Anurag Majumdar, Rami Kheireddine, Lila F Dabill, Clara Kim, Brian Kleiboeker, Fengrui Zhang, Yongbin Chen and 9 more

Abstract read
In one paragraph

Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xiao Zhang *Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Sreejith S Panicker *Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Jordan M BollingerDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Anurag MajumdarDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Rami KheireddineDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Lila F DabillDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Clara KimDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Brian KleiboekerDivision of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-3196-1803
Fengrui ZhangDepartment of Neuroscience and Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-2188-7558
Yongbin ChenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9359-6525
Kristann L MageeDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Brian S LearmanDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-3680-0061
Adam KepecsDepartment of Neuroscience and Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.
Gretchen A MeyerDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-9268-3993
Jun LiuDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-3646-0004
Steven A ThomasSystems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
Irfan J LodhiDivision of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-6246-9862
Ormond A MacDougaldDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-6907-7960
Erica L SchellerDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, USA. scheller@wustl.edu.ORCID http://orcid.org/0000-0002-1551-3816

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · 2022 to 2025
$5.6M
Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
Sarm1 and neural regulation of boneR01DK132073 · NIDDK · WASHINGTON UNIVERSITY · 2024 to 2025
$791k
RESOURCE BASED CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINEP30AR074992 · WASHINGTON UNIVERSITY · 2025 to 2025
$641k
BCFA Metabolism and the Regulation of Energy BalanceR01DK133344 · WASHINGTON UNIVERSITY · 2025 to 2025
$513k
Metabolism and functions of bone marrow adipose tissue in the marrow nicheR01DK137798 · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2025 to 2025
$455k
Mitochondrial dynamics and the control of adipose tissue thermogenesisR01DK132239 · WASHINGTON UNIVERSITY · 2025 to 2025
$389k
Parathyroid hormone (PTH) modulates lipid metabolism in the skeletal nicheR01AG069795 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$123k
NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR075773NIAMS NIH HHS R56 AR081251NIA NIH HHS R01 AG069795NIA NIH HHS RF1 AG066905NIDCR NIH HHS R00 DE024178NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK132073NIDDK NIH HHS R01 DK132239NIDDK NIH HHS R01 DK133344NIDDK NIH HHS R01 DK137798NIDDK NIH HHS U01 DK116317U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR075773U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P30-AR074992U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R56-AR081251U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) R00-DE024178U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK137798U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) P30-DK020579U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) P30-DK020593U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01-DK132073U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) U01-DK116317U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG069795U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) RF1-AG066905
6 · The paper itself

Abstract

Several adipose depots, including constitutive bone marrow adipose tissue, resist conventional lipolytic cues. However, under starvation, wasting or cachexia, the body eventually catabolizes stable adipocytes through unknown mechanisms. Here we developed a mouse model of brain-evoked depletion of all fat, including stable constitutive bone marrow adipose tissue, independent of food intake, to study this phenomenon. Genetic, surgical and chemical approaches demonstrated that catabolism of stable adipocytes required adipose triglyceride lipase-dependent lipolysis but was independent of local nerves, the sympathetic nervous system and catecholamines. Instead, concurrent hypoglycaemia and hypoinsulinaemia activated a potent catabolic state by suppressing lipid storage and increasing catecholamine-independent lipolysis via downregulation of cell-autonomous lipolytic inhibitors including G0s2. This was also sufficient to delipidate classical adipose depots and was recapitulated in tumour-associated cachexic mice. Overall, this defines unique adaptations of stable adipocytes to resist lipolysis in healthy states while isolating a potent catecholamine-independent neurosystemic pathway by which the body can rapidly catabolize all adipose tissues.

Indexed as

AdipocytesCatecholaminesLipolysisAcyltransferasesAdipose TissueAnimalsMaleMiceMice, Inbred C57BLSignal TransductionAcyltransferasesCatecholamines

Identifiers

PMID41507664
PMCPMC12855016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.